PURPOSE: Frizzled-5 (Fzd5) is expressed in the developing retina of multiple species and appears to play species-specific roles during eye development. The present study analyzed the effects of tissue-specific deletion of Fzd5 on mammalian eye development. METHODS: To generate Fzd5 conditional knockout (CKO) mice, Fzd5(+/-) mice carrying the Six3-Cre transgene were crossed with Fzd5(LoxP/LoxP) mice. To determine which cell lineages in the eye had Cre recombinase activity, Six3-Cre transgenic mice were crossed with ROSA-26 reporter mice, and lacZ activity was assayed. Histologic analysis, immunofluorescence, and TUNEL labeling were performed from embryonic day (E)12.5 to postnatal stages to analyze vascularization, cell proliferation, retinal organization, and apoptosis. RESULTS: On conditional disruption of Fzd5 specifically in the retina, but not in vitreous hyaloid vasculature (VHV), an abnormal accumulation consisting of pericytes and endothelial cells was observed in the vitreous as early as E12.5. The abundant retrolental cells persisted into postnatal stages and appeared as a pigmented intravitreal mass. In Fzd5 CKO mice there was failure of normal apoptosis of the VHV, and cells in the persistent VHV were maintained in the cell cycle up to postnatal day 23. Moreover, morphogenesis of the retina adjacent to the vasculature was disrupted, leading to retinal folds, detachment, and abnormal lamination. This phenotype is similar to that of human eye disease persistent hyperplastic primary vitreous (PHPV). CONCLUSIONS: Selective loss of Fzd5 in the retina results in PHPV and retinal defects through an apparently cell-nonautonomous effect, revealing a potential requirement for retina-derived signals in regulating the development of the VHV.
PURPOSE:Frizzled-5 (Fzd5) is expressed in the developing retina of multiple species and appears to play species-specific roles during eye development. The present study analyzed the effects of tissue-specific deletion of Fzd5 on mammalian eye development. METHODS: To generate Fzd5 conditional knockout (CKO) mice, Fzd5(+/-) mice carrying the Six3-Cre transgene were crossed with Fzd5(LoxP/LoxP) mice. To determine which cell lineages in the eye had Cre recombinase activity, Six3-Cre transgenic mice were crossed with ROSA-26 reporter mice, and lacZ activity was assayed. Histologic analysis, immunofluorescence, and TUNEL labeling were performed from embryonic day (E)12.5 to postnatal stages to analyze vascularization, cell proliferation, retinal organization, and apoptosis. RESULTS: On conditional disruption of Fzd5 specifically in the retina, but not in vitreous hyaloid vasculature (VHV), an abnormal accumulation consisting of pericytes and endothelial cells was observed in the vitreous as early as E12.5. The abundant retrolental cells persisted into postnatal stages and appeared as a pigmented intravitreal mass. In Fzd5 CKO mice there was failure of normal apoptosis of the VHV, and cells in the persistent VHV were maintained in the cell cycle up to postnatal day 23. Moreover, morphogenesis of the retina adjacent to the vasculature was disrupted, leading to retinal folds, detachment, and abnormal lamination. This phenotype is similar to that of humaneye disease persistent hyperplastic primary vitreous (PHPV). CONCLUSIONS: Selective loss of Fzd5 in the retina results in PHPV and retinal defects through an apparently cell-nonautonomous effect, revealing a potential requirement for retina-derived signals in regulating the development of the VHV.
Authors: M B Reichel; R R Ali; F D'Esposito; A R Clarke; P J Luthert; S S Bhattacharya; D M Hunt Journal: Cell Death Differ Date: 1998-02 Impact factor: 15.828
Authors: Johan H van Es; Philippe Jay; Alex Gregorieff; Marielle E van Gijn; Suzanne Jonkheer; Pantelis Hatzis; Andrea Thiele; Maaike van den Born; Harry Begthel; Thomas Brabletz; Makoto M Taketo; Hans Clevers Journal: Nat Cell Biol Date: 2005-03-20 Impact factor: 28.824
Authors: Florencia Cavodeassi; Filipa Carreira-Barbosa; Rodrigo M Young; Miguel L Concha; Miguel L Allende; Corinne Houart; Masazumi Tada; Stephen W Wilson Journal: Neuron Date: 2005-07-07 Impact factor: 17.173
Authors: Terence J Van Raay; Kathryn B Moore; Ilina Iordanova; Michael Steele; Milan Jamrich; William A Harris; Monica L Vetter Journal: Neuron Date: 2005-04-07 Impact factor: 17.173
Authors: Ivan B Lobov; Sujata Rao; Thomas J Carroll; Jefferson E Vallance; Masataka Ito; Jennifer K Ondr; Savita Kurup; Donald A Glass; Millan S Patel; Weiguo Shu; Edward E Morrisey; Andrew P McMahon; Gerard Karsenty; Richard A Lang Journal: Nature Date: 2005-09-15 Impact factor: 49.962
Authors: Li Jiang; Yuxiao Wei; Cecinio C Ronquillo; Robert E Marc; Bradley K Yoder; Jeanne M Frederick; Wolfgang Baehr Journal: J Biol Chem Date: 2015-03-30 Impact factor: 5.157
Authors: Yuri K Peterson; Patrick Nasarre; Ingrid V Bonilla; Eleanor Hilliard; Jennifer Samples; Thomas A Morinelli; Elizabeth G Hill; Nancy Klauber-DeMore Journal: Angiogenesis Date: 2017-08-24 Impact factor: 9.596
Authors: Elizabeth J Bankhead; Mary P Colasanto; Kayla M Dyorich; Milan Jamrich; L Charles Murtaugh; Sabine Fuhrmann Journal: Am J Pathol Date: 2014-11-03 Impact factor: 4.307
Authors: Jianmin Zhang; Russell J Taylor; Anna La Torre; Matthew S Wilken; Kristen E Cox; Thomas A Reh; Monica L Vetter Journal: Dev Biol Date: 2015-05-16 Impact factor: 3.582
Authors: Alexander I Son; Michal Sheleg; Margaret A Cooper; Yuhai Sun; Norman J Kleiman; Renping Zhou Journal: Invest Ophthalmol Vis Sci Date: 2014-03-19 Impact factor: 4.799
Authors: Susov Dhakal; Craig B Stevens; Meyrav Sebbagh; Omri Weiss; Ruth A Frey; Seth Adamson; Eric A Shelden; Adi Inbal; Deborah L Stenkamp Journal: Dev Dyn Date: 2015-09-02 Impact factor: 3.780